Welcome to the Cannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelic Stock News Stories for the Week of June 29th – July 5th, 2020.
Without further ado, let’s get started.
* Yahoo Finance readers, please click here to view full article.
The pandemic first hit the U.S. earlier this year. The cannabis industry was deemed as essential and legal sales nationwide soared. With a possible second wave of the virus underway, investors should look at companies such as Red White & Bloom TDRYD, which controls a dominant 22% share of the Michigan market and compared to its multi-state operator (MSO) peers, is trading at an extremely attractive valuation.
9. Patents for Psychedelics: “We Have the Potential to All Be Winners if We Do This Right”
Consider: In April, MindMed MMEDF, working with the University Hospital Basel’s Laboratory, in Basel, Switzerland in a deal to support clinical trials and secure exclusive patent rights, discovered and filed a patent in the U.S. preserving all worldwide rights for a neutralizer technology that can shorten or even stop the hallucinogenic effects of LSD in a therapy session.
READ FULL PSYCHEDELICS PATENTS ARTICLE
8. Cronos Group: Raymond James Sees US$4.10/Share Valuation Just for Ginkgos Partnership
Raymond James Has Created a Valuation Method Specific to Cannabinoid Biosynthesis
Raymond James recently upgraded Cronos Group CRON to an Outperform 2 rating as well as almost doubling their price target to C$13.52 / U$10. The justification behind this was that they believe Cronos’ partnership with Ginkgo Bioworks currently adds $1.54 billion or US$4.10 a share in value.
READ FULL CRONOS GROUP ARTICLE
7. Curaleaf Unveils Nationwide Expansion Plans for Select Brand
Curaleaf CURLF announced the continued expansion of its line of Select brand into new markets including Maine, Massachusetts, Ohio and Florida between now and August 2020.
6. Health Canada: ‘Any Celebrity Affiliation with Cannabis Has Potential to be Non-Compliant’
Last week, Organigram OGI announced it was making adjustments to the Trailer Park Buds brand after discussions with the regulator. Other Canadian licensed producers (LPs) with celebrity ties include Canopy Growth CGC (Snoop Dogg’s Leafs by Snoop and Seth Rogen‘s Houseplant brand), Tilray TLRY (Marley Natural-branded vape cartridges) and Supreme Cannabis SPRWF (Wiz Khalifa’s Khalifa Kush).
READ FULL HEALTH CANADA ARTICLE
5. Better Cannabis Stock: Aphria vs. Canopy Growth
Which of These Struggling Pot Stocks Should You Buy?
Today, I’ll look at two of the top Pot Stocks in the industry — Aphria APHA and Canopy Growth CGC — and assess which of these leading cannabis producers is the better stock to hold in your portfolio.
READ FULL APHA VS WEED ARTICLE
4. Can Cannabis 2.0 Products Boost Canopy Growth and Organigram in 2020?
While all marijuana companies ramped up production to grab the opportunities of this new market, Canopy Growth CGC and Organigram OGI have focused on providing the most innovative products to consumers.
READ FULL CANNABIS 2.0 ARTICLE
3. Psychedelics Outlook: A New Industry Emerges
The idea of investing in Psychedelics has captured the attention of the market, but what’s next for this exciting new segment?
READ FULL PSYCHEDELICS INVESTING ARTICLE
2. The 3 Marijuana Stocks You’ll Want to Own for the Second Half of 2020
While all “next big thing” industries need time to mature (and cannabis is no different), the following three Marijuana Stocks are the names you’ll want to own for the second half of 2020: Green Thumb GTBIF, Innovative Industrial Properties IIPR and Scotts Miracle-Gro SMG.
READ FULL MARIJUANA STOCKS ARTICLE
Revive Therapeutics RVVTF announced it has submitted today its Investigational New Drug (“IND”) application to the U.S. Food and Drug Administration (FDA) for a Phase 3 confirmatory study for Bucillamine as a potential treatment in COVID-19.
READ FULL REVIVE THERAPEUTICS ARTICLE
Photo by Matteo Paganelli on Unsplash
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Click on the image for more info.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry?
Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.
Get your tickets now before prices surge by following this link.